Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
نویسندگان
چکیده
منابع مشابه
Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, VerifyNow, and thrombelastography in patients undergoing percutaneous coronary intervention.
BACKGROUND A reduced response to aspirin and clopidogrel predicts ischemic events, but reliable tests are needed to identify low responders. We compared 3 platelet-function tests during long-term dual treatment with aspirin and clopidogrel. METHODS Patients who underwent a percutaneous coronary intervention and were receiving a combination of 325 mg/day aspirin and 75 mg/day clopidogrel were ...
متن کاملmodern surgical techniques in treatment of patients with cleft lip & cleft palate
چکیده ندارد.
15 صفحه اولComparing jumping to conclusion and personalization biases in schizophrenic patients with and without medication therapy
Introduction: Previous studies have reported contradicting results about the effect of medication therapy on attribution bias and jumping to conclusion (JTC) bias in schizophrenic patients. This study aims at analyzing the effect of medication on attribution bias and JTC bias in schizophrenic patients. Methods: This study is an ex post facto and casual-comparative research. 28 people includi...
متن کاملFurther ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
Aspirin remains the cornerstone antiplatelet agent for primary and secondary prevention in patients with diabetes mellitus (DM), a disease associated with heightened platelet reactivity, endothelial dysfunction, and inflammation.1,2 Patients with DM are at a greater risk of death, myocardial infarction, and stroke resulting from thrombotic event occurrence than are patients without diabetes. Be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diagnostics
سال: 2020
ISSN: 2075-4418
DOI: 10.3390/diagnostics10110871